fda warning letter compounding semaglutide october 2025 Troubling Findings in Study of GLP-1 Compounders Compounded "semaglutide" is not FDA-approved

The supplier blend (Ion Peptides) comes in two ratios in a 3 mL maximum vial : a 10/3 vial (10 mg tesamorelin + 3 mg ipamorelin, 13 mg total) and a 5/5 vial (5 mg tesamorelin + 5 mg ipamorelin, 10 mg total)

[1] ALCAR modulates phospholipid metabolism and synaptic morphology while enhancing synthesis of neurotrophic factors and neurotransmitters

BPC-157 and TB-500 timelines: tendon and soft-tissue inflammation drops, joint discomfort improves, gut symptoms quiet down

Targeting this pathway offers a promising strategy for cancer therapy, especially in combination with other treatments

TB-500 creates systemic healing support through enhanced cell migration and reduced inflammation

We are here to support your journey to better health with personalized, cutting-edge treatments